Skip to content

QUANTRX BIOMEDICAL CORP

company.status.inactive

CIK 820608fmd_1X8EWCMFR4E3C8F62YJ8BB44J8Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2022, 51 periods

Income Statement · Annual · Millions · USD
Line itemFY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021
Total revenues000000000–
Cost of revenue––––––––––
Gross profit––––––––––
Realized investment gains (losses)––––00(0)(0)0–
Research and development00000–––––
Selling, general and administrative0000000000
Operating income(0)(0)(0)(0)(0)(0)(0)(0)(0)(0)
Interest expense0000000000
Interest and investment income000–––––––
Other non-operating income (expense)–––(0)(0)1(1)(0)(0)(0)
Income before taxes(1)(0)(1)(0)(0)1(1)(1)(0)(0)
Income tax expense–––000000–
Net income from continuing operations(1)––(0)(0)1(1)(1)(0)–
Net income(1)(0)(1)(0)(0)1(1)(1)(0)(0)
Net income to common shareholders(1)(0)(1)(0)––––––
QUANTRX BIOMEDICAL CORP financial statements · FinancialMD